PL
TDOC icon

Pluribus Labs’s Teladoc Health TDOC Stock Holding History

Pluribus Labs’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$234K Buy
+7,051
New +$299K 0.43% 80
2022
Q1 		– Sell
-2,744
Closed -$252K – 203
2021
Q4 		$252K Buy
+2,744
New +$328K 0.27% 166

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Pluribus Labs's TDOC Position: Q2 2022 in Review

Pluribus Labs opened a new position in Teladoc Health (TDOC) in Q2 2022: 7,051 shares worth $234K. The stake represents 0.43% of the portfolio and ranks #80 among its holdings. This is a return to the name: Pluribus Labs previously reported a position in TDOC as recently as Q4 2021.

Pluribus Labs first reported a position in TDOC in Q4 2021 and has held it in 2 quarters since. The position peaked at $252K in Q4 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Pluribus Labs held 7,051 shares of Teladoc Health worth $234K as of Q2 2022.
  • Teladoc Health was a new Pluribus Labs position in Q2 2022.
  • Teladoc Health made up 0.43% of Pluribus Labs's portfolio in Q2 2022, its #80 holding.
  • Pluribus Labs first reported a position in Teladoc Health in Q4 2021 and has held it in 2 quarters since.
  • Pluribus Labs's Teladoc Health position peaked at $252K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.